Global Pharmaceutical Distribution Conference



Pharma IQ
08/09/2013

  • Do you understand the latest requests from the regulatory authorities and how best to comply?
  • Are you prepared for the new ambient temperature regulatory requirements?
  • Are you already implementing the required changes to controlled temperature distribution, validation & qualification, and risk management requirements?

If you answered no to any of the above, you only have six months to get to grips with the latest guidelines and make the necessary changes!

 We are here to help you get prepared. We have just released the new agenda for Pharma IQ’s 4th Annual Pharmaceutical Distribution Summit and it specifically covers the most pressing issues in pharmaceutical distribution, including a focused morning session on the new GDP guidelines. Taking place from the 23rd -25th September in London, the summit agenda boasts more than 25 international speakers from the world's largest pharmaceutical companies; this meeting brings together global expertise to assist you in improving your supply chain.

Top five highlights include:

1-GDP Focus morning
Specific Aspects of the Revised EU GDP Guidelines
Regulatory guidance on the new GDP guidelines – what is required? How can they be implemented?
Riekert Bruinick, Chief, Dutch Healthcare Inspectorate & Member of the EMA GDP Draft Writing Committee

2Case Study from Celgene
 Implementing and Integrating a Central European Distribution Model: a case study of  trials and tribulations
Exploring the lessons to be learnt from Celgene’s current project.
Hubert Koevoets, Director Distribution Europe & Transactional Management, Celgene

3- Case study from Bristol-Myers Squibb
Successfully  Sourcing Logistics Partners in Emerging Markets and Marginal Countries

Case study exploring BMS’ approach to dealing with marginal countries where finding logistics partners is a crucial challenge.
Cedric Merlet, EMEA Associate Director Global Procurement Logistics, Bristol-Myers Squibb

4 -GE Healthcare session
Challenges in the Distribution of Short-Lived Radioactive Pharmaceuticals
How do regulations impact the availability of radiopharmaceuticals to patients, and do they “understand” radiopharmaceuticals?
Rob Dekkers, Logistics and Distribution Leader EMEA,
GE Healthcare

5 - Interactive workshop
Quality Management in Your Cold Supply Chain
Dedicated session exploring the important issue of maintaining quality standards for your cold supply chain.
Saddam Huq, QA Senior Manager, Global Logistics & Cold Chain,  GSK

Whether you’re in need of clarity over the GDP updates, want to explore the idea of expanding your networks in emerging markets, or looking to ensure you’re running a secure supply chain, this meeting has it all in one place.

Book today and save!  Register before 31st May 2013 and save up to €400. For more information or to register:

Online: www.distributioneurope.com